Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Erratum: High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers

    Correction to: British Journal of Cancer (2015) 112, 739–744. doi:10.1038/bjc.2015.1; Published online 27 January 2015 Following publication of the above paper in the British Journal of Cancer, the authors not...

    M Miyamoto, M Takano, K Iwaya, N Shinomiya, T Goto, M Kato in British Journal of Cancer (2017)

  2. No Access

    Article

    The hypusine cascade promotes cancer progression and metastasis through the regulation of RhoA in squamous cell carcinoma

    Metastasis is a critical factor contributing to poor prognosis in cancer, but the underlying mechanisms of metastasis are still poorly understood. We established a highly metastatic cell subline (HOC313-LM) de...

    T Muramatsu, K-i Kozaki, S Imoto, R Yamaguchi, H Tsuda, T Kawano, N Fujiwara in Oncogene (2016)

  3. Article

    Open Access

    High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers

    High-temperature-required protein A2 (HtrA2), a protein relating with apoptosis in a caspases-dependent and non-dependent manner, has been reported to be associated with chemosensitivity in several human cancers.

    M Miyamoto, M Takano, K Iwaya, N Shinomiya, T Goto, M Kato in British Journal of Cancer (2015)

  4. Article

    Open Access

    Overexpression of SMYD2 contributes to malignant outcome in gastric cancer

    SET and MYND domain-containing protein 2 (SMYD2) is a lysine methyltransferase for histone H3, p53 and Rb and inhibits their transactivation activities. In this study, we tested whether SMYD2 (1q42) acts as a can...

    S Komatsu, D Ichikawa, S Hirajima, H Nagata, Y Nishimura in British Journal of Cancer (2015)

  5. Article

    Open Access

    Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay

    For patients with breast cancer treated with preoperative chemotherapy, residual tumour burden in lymph nodes is the strongest prognostic factor. However, conventional pathological examination has limitations ...

    T Osako, H Tsuda, R Horii, T Iwase, H Yamauchi, H Yagata in British Journal of Cancer (2013)

  6. Article

    Open Access

    Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma

    Several studies have demonstrated that YWHAZ (14-3-3ζ), included in the 14-3-3 family of proteins, has been implicated in the initiation and progression of cancers. We tested whether YWHAZ acted as a cancer-promo...

    Y Nishimura, S Komatsu, D Ichikawa, H Nagata, S Hirajima in British Journal of Cancer (2013)

  7. Article

    Open Access

    Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms

    The molecular basis for the development of appendiceal mucinous tumours, which can be a cause of pseudomyxoma peritonei, remains largely unknown.

    G Nishikawa, S Sekine, R Ogawa, A Matsubara, T Mori in British Journal of Cancer (2013)

  8. No Access

    Article

    SIX1 promotes epithelial–mesenchymal transition in colorectal cancer through ZEB1 activation

    Epithelial–mesenchymal transition (EMT) has a major role in cancer progression, as well as normal organ development and human pathology such as organ fibrosis and wound healing. Here, we performed a gene expre...

    H Ono, I Imoto, K Kozaki, H Tsuda, T Matsui, Y Kurasawa, T Muramatsu in Oncogene (2012)

  9. Article

    Open Access

    Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast

    We previously reported that the primary tumour/vessel tumour/nodal tumour (PVN) classification is significantly superior to the UICC pTNM classification and the Nottingham Prognostic Index for accurately predi...

    T Hasebe, M Iwasaki, S Akashi-Tanaka, T Hojo, T Shibata in British Journal of Cancer (2011)

  10. Article

    Open Access

    Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation

    Tumour necrosis reflects the presence of hypoxia, which can be indicative of an aggressive tumour phenotype. The aim of this study was to investigate whether histological necrosis is a useful predictor of outc...

    N Hiraoka, Y Ino, S Sekine, H Tsuda, K Shimada, T Kosuge in British Journal of Cancer (2010)

  11. Article

    Open Access

    Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy

    Although a pathologic complete response (pCR) after neoadjuvant chemotherapy is associated with favourable outcomes, a small proportion of patients with pCR have recurrence. This study was designed to identify...

    M Tanioka, C Shimizu, K Yonemori, K Yoshimura, K Tamura in British Journal of Cancer (2010)

  12. Article

    Open Access

    Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix

    A retrospective analysis was carried out to identify risk factors for survival and relapse in patients with FIGO stage I–IIB cervical adenocarcinoma (AC), who underwent radical hysterectomy, and to compare out...

    T Kasamatsu, T Onda, M Sawada, T Kato, S Ikeda, Y Sasajima in British Journal of Cancer (2009)

  13. Article

    Open Access

    Can ABCF2 protein expression predict the prognosis of uterine cancer?

    Uterine cervical and endometrial cancers are common malignant solid neoplasms for which there are no useful prognostic markers. In this study, we evaluate the relationship between ATP-binding cassette superfam...

    S Nishimura, H Tsuda, Y Miyagi, A Hirasawa, A Suzuki in British Journal of Cancer (2008)

  14. Article

    Open Access

    The involvement of FOXO1 in cytotoxic stress and drug-resistance induced by paclitaxel in ovarian cancers

    The role of transcriptional factor FOXO1 in the mechanism of drug-resistance in ovarian cancer has not been elucidated. In ovarian cancer cell lines, FOXO1 expression and its correlation with paclitaxel treatm...

    T Goto, M Takano, J Hirata, H Tsuda in British Journal of Cancer (2008)

  15. No Access

    Article

    Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma

    Epigenetic alterations and the resulting inactivation of tumor suppressor genes often contribute to the development of various cancers. To identify novel candidates that may be silenced by aberrant methylation...

    K Tanaka, I Imoto, J Inoue, K Kozaki, H Tsuda, Y Shimada, S Aiko, Y Yoshizumi in Oncogene (2007)

  16. No Access

    Article

    Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis

    Homozygous loss in the genomic sequence, a mechanism for inactivating tumor-suppressor genes (TSGs) in cancer, has been used as a tag for the identification of novel TSGs, and array-based comparative genomic h...

    H Takada, I Imoto, H Tsuda, Y Nakanishi, C Sakakura, S Mitsufuji, S Hirohashi in Oncogene (2006)

  17. Article

    Open Access

    Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging

    A retrospective analysis was performed to evaluate the clinical characteristics and prognostic factors in the patients with clear cell carcinoma (CCC) of the ovary. After central pathological review and scanni...

    M Takano, Y Kikuchi, N Yaegashi, K Kuzuya, M Ueki, H Tsuda in British Journal of Cancer (2006)

  18. Article

    Open Access

    Phase I–II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer

    Combination chemotherapy with irinotecan (CPT-11) and platinum compounds is effective for treating cervical cancer. Nedaplatin (254-S) is a new cisplatin analogue that achieves a high response rate (53%) in pa...

    H Tsuda, Y Hashiguchi, S Nishimura, M Miyama, S Nakata in British Journal of Cancer (2004)

  19. No Access

    Article

    The significance of bivariate cytokeratin and DNA flow cytometry in paraffin-embedded specimens of non-small cell lung cancer

    H. Otsuka, S. Funai, H. Tsuda, T. Azumi in International Journal of Clinical Oncology (2001)

  20. No Access

    Chapter

    Urinary System

    G. C. Hard, B. Durchfeld-Meyer, B. Short in International Classification of Rodent Tum… (2001)

previous disabled Page of 2